Active Ingredient (In Each 5Ml)
Docusate Sodium 100 mg
The following Structured Product Label (SPL) was submitted to the FDA by Kesin Pharma Corporation for the product Docusate Sodium Oral Liquid (NDC 81033-022). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each 5ml), purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, overdosage, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Docusate Sodium 100 mg
Stool Softener Laxative
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| Age | Dose |
| adults and children 12 years and older | 1 to 7 teaspoonfuls |
| children 2 to under 12 years of age | 1 to 3 teaspoonfuls |
| children under 2 years of age | ask a doctor |
NDC 81033-022-10: 10 mL unit dose cup
NDC 81033-022-50 : Case containing 100 unit dose cups of 10 mL each
citric acid, grape flavor, methylparaben, monoammonium glycyrrhizinate, potassium citrate, propylene glycol, propylparaben, purified water, sorbitol, sucralose
Call 1-833-537-4679
Packaged by:
Kesin Pharma
Oldsmar, FL 34677
Rev. 04/2025
NDC 81033-022-50
Docusate Sodium Oral Liquid 100 mg/10 mL
Delivers 10 mL Case = 100 UD Cups (Do Not Break Case)
Storage: 68°F to 77°F (20°C to 25°C)
QTY: 1
* Please review the disclaimer below.